Physical Impairments in Allogeneic-HSCT
Physiological Responses to Maximal Exercise Capacity and Muscle Strength in Survived Hematopoietic Stem Cell Transplantation Recipients
1 other identifier
observational
122
1 country
1
Brief Summary
Pulmonary functions, exercise capacity and muscle strength deteriorate in survived hematopoietic stem cell transplantation (HSCT) recipients due to toxic effects of chemotherapy, radiotherapy, conditioning regimens and/or corticosteroid use before HSCT, prolonged stay of recipients in rooms with laminar airflow and strict infection control rules during process of HSCT. There are also limited numbers of studies demonstrated pulmonary function abnormalities, decreased maximal exercise capacity, respiratory and peripheral muscle weakness in recipients. Current study was planned since no study compared pulmonary functions, maximal exercise capacity, respiratory and peripheral muscle strength between recipients and healthy individuals in the literature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
February 22, 2018
CompletedFirst Posted
Study publicly available on registry
February 28, 2018
CompletedApril 16, 2019
April 1, 2019
2.7 years
February 22, 2018
April 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Modified-Incremental Shuttle Walk Test (ISWT)
This test was used to evaluate maximal exercise capacity
15-20 minutes
Secondary Outcomes (3)
pulmonary function test
5 minutes
inspiratory and expiratory muscle strength (MIP, MEP)
5-10 minutes
Quadriceps femoris muscle strength
5 minutes
Study Arms (2)
Group 1: HSCT recipients
Pulmonary functions \[spirometry\], maximal exercise capacity \[Modified-Incremental Shuttle Walk Test (ISWT)\], inspiratory and expiratory muscle strength (MIP and MEP, respectively) \[mouth pressure device\] and peripheral muscle strength \[hand-held dynamometer\] were evaluated in allogeneic HSCT recipients (n=66).Vital signs, dyspnea and fatigue perception \[Modified Borg Scale\] were recorded as pre-post measurements of Modified-ISWT.
Group 2: healthy individuals
Healthy individuals (n=50) were selected from individuals without known and diagnosed any chronic diseases. Similar measurements were applicated in healthy individuals.
Eligibility Criteria
66 recipients underwent allogeneic HSCT who were at minimum 100 days status post-transplantation compared with 50 healthy individuals. All recipients transplanted at the Bone Marrow Transplantation Unit of University Faculty of Medicine. All measurements were done by a physiotherapist at Cardiopulmonary Unit of University Faculty of Health Science Department of Physiotherapy and Rehabilitation. Demographic and clinical characteristics of all participants were recorded. Study was planned as retrospective, cross sectional and approved by the local Ethics Committee. Informed consent was obtained from all individual participants included in the study.
You may qualify if:
- between ages of 18 and 70
- under standard medical treatment
- underwent allogeneic HSCT who were at minimum 100 days status post-transplantation
You may not qualify if:
- having cognitive disorder, orthopedic or neurological disease with a potential to affect assessment of maximal exercise capacity,
- having comorbidities such as asthma, chronic obstructive pulmonary disease (COPD), acute respiratory or other infections,
- having problems like visual and mucositis which may prevent measurements,
- acute hemorrhage anywhere in the body,
- hemoglobin value less than 8 g/L and platelet count less than 10.000 mm3
- being individuals without known and diagnosed any chronic diseases
- not actively smoking
- their cigarette exposure is not greater than 5 pack\*year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University Faculty of Health Science Department of PhysioTherapy
Ankara, 06010, Turkey (Türkiye)
Related Publications (7)
Kovalszki A, Schumaker GL, Klein A, Terrin N, White AC. Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008 Jun;41(11):965-9. doi: 10.1038/bmt.2008.15. Epub 2008 Feb 11.
PMID: 18264142RESULTMorishita S, Kaida K, Yamauchi S, Sota K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K. Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients. Support Care Cancer. 2013 Aug;21(8):2161-9. doi: 10.1007/s00520-013-1778-7. Epub 2013 Mar 9.
PMID: 23475197RESULTKnols RH, de Bruin ED, Uebelhart D, Aufdemkampe G, Schanz U, Stenner-Liewen F, Hitz F, Taverna C, Aaronson NK. Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transplant. 2011 Sep;46(9):1245-55. doi: 10.1038/bmt.2010.288. Epub 2010 Dec 6.
PMID: 21132025RESULTShelton ML, Lee JQ, Morris GS, Massey PR, Kendall DG, Munsell MF, Anderson KO, Simmonds MJ, Giralt SA. A randomized control trial of a supervised versus a self-directed exercise program for allogeneic stem cell transplant patients. Psychooncology. 2009 Apr;18(4):353-9. doi: 10.1002/pon.1505.
PMID: 19117328RESULTMorishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Ogawa H, Domen K. Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stem-cell transplantation. Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12669. Epub 2017 Feb 21.
PMID: 28220548RESULTBargi G, Guclu MB, Aribas Z, Aki SZ, Sucak GT. Inspiratory muscle training in allogeneic hematopoietic stem cell transplantation recipients: a randomized controlled trial. Support Care Cancer. 2016 Feb;24(2):647-659. doi: 10.1007/s00520-015-2825-3. Epub 2015 Jul 2.
PMID: 26135532RESULTBird L, Arthur A, Niblock T, Stone R, Watson L, Cox K. Rehabilitation programme after stem cell transplantation: randomized controlled trial. J Adv Nurs. 2010 Mar;66(3):607-15. doi: 10.1111/j.1365-2648.2009.05232.x.
PMID: 20423395RESULT
Study Officials
- STUDY CHAIR
Gülşah Barğı, PhD
Gazi University
- STUDY DIRECTOR
Meral Boşnak Güçlü, PhD
Gazi University
- PRINCIPAL INVESTIGATOR
Gülsan Türköz Sucak
Bahçeşehir University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
February 22, 2018
First Posted
February 28, 2018
Study Start
March 1, 2012
Primary Completion
November 1, 2014
Study Completion
December 1, 2017
Last Updated
April 16, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make individual participant data but when the statistical analyses of all data are made, all results will be shared.